Prof. Kuan-Pin Su

 

Academic Degree(s)

Professor & Chairman

 

E-Mail

cobolsu@gmail.com

 

Current Position

  • Professor and Vice Dean, College of Medicine, China Medical University, Taichung, Taiwan
  • Director, Mind-Body Interface Laboratory (MBI-Lab), China Medical University Hospital, Taichung, Taiwan

 

Professional Experience

  • 2008/11-, Honorary Faculty of Stress, Psychiatry and Immunology Laboratory (SPI-Lab), Institute of Psychiatry-King's College London
  • 1999/5-2002/3, Attending physician, Department of Psychiatry, Wan Fang Medical Centre & Taipei Medical University Hospital

 

Education & Training

  • 1988-1995, M.D., Kaohsiung Medical College, Kaohsiung, Taiwan
  • 1995-1999, Chief Resident and Resident, Taipei City Psychiatric Centre
  • 2005-2008, PhD, Institute of Psychiatry, King’s College London, UK

 

Awards

  • 2016, The International Society for the Study of Fatty Acids and Lipids (ISSFAL): Early Career Award
  • 2013, Psychopharmacology Award from the British Association for Psychopharmacology (UK)
  • 2012 and 2010, The International Society for the Study of Fatty Acids and Lipids (ISSFAL): New Investigator Award
  • 2011, Thomson Reuters Research Front Award
  • 2010, Ta-You Wu Memorial Award (國科會吳大猷獎), National Science Council, Taiwan

 

Research Grants

  • Biological mechanisms and clinical subtyping for comorbidity of chronic pain and depression: The molecular approach of central sensitization. (2017-2020, MOST106-2314-B-039-027-MY3)
  • N-3 fatty acids as the first-line antidepressant therapy: From biomarkers to clinical subtypes (2016-2018, 3-Year Innovative Research Grant (IRG) of Integrated Research Grants in Health and Medical Sciences from National Health Research Institutes NHRI-EX105-10528NI)
  • Pharmacogenomics of n-3 polyunsaturated fatty acids treatment for major depressive disorder: Genome-wide associations. (2014-2017, Ministry of Science and Technology)
  • Major depression and omega-3 fatty acids: From cellular mechanisms to clinical implications (2014-2016, NCBR [National Centre for Research and Development, Poland] and Taiwan Ministry of Science and Technology Joint Research Projects)
  • Neuropsychobiology of Brain Theta-burst Stimulation: A Mind-body Interface for Depression (2012-2014, Innovative Research Grant (IRG) of Integrated Research Grants in Health and Medical Sciences from National Health Research Institutes NHRI-EX101-10144NI)

 

Committee & Membership

  • Member of Board of Directors, the International Society for the Study of Fatty Acids and Lipids (ISSFAL) (2016-2020)
  • Council Board Member of the International Society for Nutritional Psychiatry Research (ISNPR) (since 2013)
  • President of Taiwan Society for Nutritional Psychiatry Research (TSNPR) (since 2016)

 

Selected Publication

  • Lin PY, Chang CH, Chongc MFF, Chen H, Su KP*. Polyunsaturated fatty acids in perinatal depression: A systematic review and meta-analysis. Biological Psychiatry (Accepted) doi: 10.1016/j.biopsych.2017.02.1182. [Epub ahead of print]
  • Chang JPC, Su KP, Mondelli V, Pariante C. Omega-3 Polyunsaturated Fatty Acids in Youths with Attention Deficit Hyperactivity Disorder (ADHD): A Systematic Review and Meta-analysis of Clinical Trials and Biological Studies. Neuropsychopharmacology (Accepted) doi: 10.1038/npp.2017.160. [Epub ahead of print]
  • Sarris J, Logan A, Akbaraly T, Amminger GP, Balanzá-Martínez V, Freeman MP, Hibbeln J, Matsuoka Y, Mischoulon D, Mizoue T, Nanri A, Nishi D, Ramsey D, Rucklidge JJ, Sanchez-Villegas A, Scholey A, Su KP, Jacka FN. Nutritional Medicine as Mainstream in Psychiatry. Lancet Psychiatry 2015 Mar; 2(3): 271-4.
  • Chang JPC, Chang SS, Yang HT, Palani M, Chen CP, Su KP*. Polyunsaturated fatty acids levels in patients with cardiovascular diseases with and without depression. Brain, Behavior, and Immunity 2015 Feb; 44: 28-31.
  • Sarris J, Logan A, Akbaraly T, Amminger GP, Balanzá-Martínez V, Freeman MP, Hibbeln J, Matsuoka Y, Mischoulon D, Mizoue T, Nanri A, Nishi D, Ramsey D, Rucklidge JJ, Sanchez-Villegas A, Scholey A, Su KP, Jacka FN. International Society for Nutritional Psychiatry Research consensus position statement: nutritional medicine in modern psychiatry. World Psychiatry 2015 Oct; 14(3): 370-1.
  • Su KP, Lai HC, Yang HT, Su WP, Peng CY, Chang JPC, Huang CL, Chang HC, Pariante CM. Omega-3 fatty acids in the prevention of interferon-alpha-induced depression Results from a randomized, controlled trial. Biological Psychiatry 2014 Oct 1; 76(7): 559-66.
  • Lin PY, Mischoulon D, Freeman MP, Matsuoka Y, Hibbeln J, Belmaker RH, Su KP*. Are omega-3 fatty acids anti-depressants or just mood-improving agents? The effect depends upon diagnosis, supplement preparation, and severity of depression. Molecular Psychiatry 2012 Dec; 17(12): 1161-3.
  • Lu DY, Tsao YY, Leung YM, Su KP*. Docosahexaenoic acid suppresses neuroinflammatory responses and induces heme oxygenase-1 expression in BV-2 microglia: Implications of antidepressant effects for omega-3 fatty acids. Neuropsychopharmacology 2010 Oct; 35(11): 2238–2248. (*Correspondence).
  • Lin PY, Huang SY, Su KP*. A meta-analytic review of polyunsaturated fatty acid compositions in patients with depression. Biological Psychiatry 2010; 68(2):140-147. (*Correspondence).
  • Su KP, Huang SY, Peng CY, Lai CH, Huang CL, Chen YC, Aitchison KJ, Pariante CM. Phospholipase A2 and cyclo-oxygenase 2 genes influence the risk of interferon-alpha-induced depression by regulating polyunsaturated fatty acids levels. Biological Psychiatry 2010; 67(6): 550-557.